Today, we have the privilege of speaking with Dr. Ivan Kairatov, a leading biopharma expert whose research has illuminated the intricate connections between lipid genetics and liver health. We'll be exploring the often-overlooked condition of Familial Hypobetalipoproteinemia, or FHBL, and how this
In the face of a life-altering diagnosis, the search for hope can lead patients and their families down countless digital rabbit holes, where unscrupulous vendors lie in wait with promises of miraculous cures sold through slick websites and persuasive social media campaigns. The U.S. Food and Drug
In a landmark development for reproductive medicine, a novel messenger RNA (mRNA) treatment has successfully repaired uterine damage and restored fertility in mice, offering a potential new path forward for treating certain forms of human infertility. The study, detailed in Nature Nanotechnology ,
In the high-stakes world of biopharma, few stories are as compelling as the race to develop a successor to a multi-billion-dollar drug. We're joined today by Ivan Kairatov, a biopharma expert with deep experience in research, development, and the intricate dance between clinical data and commercial
Today we're speaking with Dr. Ivan Kairatov, a biopharma expert whose work is at the very intersection of technology and immunology. His research has illuminated a fundamental biochemical pathway that governs how our immune cells maintain the health of our organs. We’ll be exploring his recent
A groundbreaking collaborative study has revealed a critical vulnerability within the human immune system, uncovering a sophisticated mechanism of viral sabotage that fundamentally alters our understanding of how pathogens outsmart our natural defenses. Research has identified a single tissue
